智通财经APP讯，金斯瑞生物科技(01548)发布公告，Ross Allen Grossman由非执行董事调任为独立非执行董事。
独立非执行董事Alphonse Galdes已获委任为审核委员会新任成员。独立非执行董事张耀梁将于公司即将举行的股东周年大会结束后继任审核委员会主席，接替将在公司即将召开的股东周年大会上退任的独立非执行董事戴祖勉。
Ross Allen Grossman已获委任为薪酬委员会新任成员。独立非执行董事施晨阳将于公司即将举行的股东周年大会结束后继任薪酬委员会主席，接替将在公司即将召开的股东周年大会上退任的独立非执行董事戴祖勉。
执行董事王烨已获委任为提名委员会新任成员，以上变动自2025年3月1日生效。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.